Sarah E. Ray

Sarah E. Ray

Auto-generated profile, based on publicly available information

Sarah E. Ray

Center for Communication Science, RTI International, Research Triangle Park, NC, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2017 in Journal of Medical Internet Research
Verified
Journal Article
Open access
DRDouglas J Rupert
Douglas J Rupert
JPJon A Poehlman
Jon A Poehlman
JHJennifer J Hayes
Jennifer J Hayes
SRSarah E Ray
Sarah E Ray
RMRebecca R Moultrie
Rebecca R Moultrie
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

14 February 2019 in Public Health
Verified
Journal Article
Closed access
LSLinda Braffird Squiers
Linda Braffird Squiers
MLMolly McKnight Lynch
Molly McKnight Lynch
SDS. Dolina
S. Dolina
SRS. Ray
S. Ray
BKB. Kelly
B. Kelly
LML. McCormack
L. McCormack

1 September 2018 in Preventive Medicine Reports
Verified
Journal Article
Open access
BSBrian Southwell
Brian Southwell
SPSarah A. Parvanta
Sarah A. Parvanta
MJMihaela M. Johnson
Mihaela M. Johnson
AOAmie C. O'DOnoghue
Amie C. O'DOnoghue
HSHelen W. Sullivan
Helen W. Sullivan
NMNancy McKenna
Nancy McKenna
Public health researchers face important challenges if they wish to include measures of hearing or cognitive ability in risk communication studies. We sought validity evidence for self-report measures of hearing and cognitive ability by comparing those measures to performance-based measures and risk information recall. We measured hearing ability (with audiologist-assisted assessment and self report), cognitive ability (with an established performance task and self report), and reactions to direct-to-consumer prescription drug promotion with adults 18 and older (n = 1064) in North Carolina, USA, in 2017. We found moderate correspondence between self-reported hearing loss and audiologist-assessed hearing loss. Both measures also showed a small negative association with recall of presented risk information. Cognitive ability results suggested less substantial correspondence between self report and performance task and the measures differed in predicting risk recall. Our results suggested a moderately efficient measure for hearing ability for research on risk information exposure and retention, and yet also suggested the need for caution regarding future use of self-reported cognitive ability as a substitute for a performance-based measure.

6 August 2022 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
SRSarah E Ray
Sarah E Ray
VBVanessa Boudewyns
Vanessa Boudewyns
CDChristine Davis
Christine Davis
JTJanice P Tzeng
Janice P Tzeng
ISIla Srivastava
Ila Srivastava
KFKaren B Feibus
Karen B Feibus
Purpose: This qualitative study explored patients’ attitudes about and perceptions of generic dry powder inhaler (DPI) substitution for the brand product and patients’ views of generic product quality, efficacy, design, and usability. Methods: Forty COPD and asthma patients (36 adults, four adolescents), who were actively using a brand DPI product, participated in one of six focus groups. Participants completed a journey mapping exercise to assess attitudes and opinions about a scenario where they refill their prescription and unexpectedly receive a generic DPI instead of their brand DPI. The focus groups were audio recorded, transcribed, and analyzed thematically. Results: The hypothetical scenario of unexpectedly receiving a generic DPI elicited mixed feelings including: happiness and relief about potential cost savings, confusion, disappointment, anger, and/or frustration with the unexpected switch. Participants in most groups anticipated anxiety or hesitation in using the generic DPI due to concerns about potential differences in usability, uncertainty about correct use, and questions about efficacy. Participants across all groups said they would ask a pharmacist or healthcare provider for information or answers to their questions, and some participants said they would use online resources. When participants held the brand and generic DPI devices, most preferred the brand DPI device and found it easier, less cumbersome, or more convenient to use (due to size and weight). However, many participants reiterated that the potential reduced cost of the generic DPI would be a primary factor in their decision-making related to generic DPI substitution for their brand DPI. Conclusion: Patients experienced a mixture of positive and negative feelings when faced with an unexpected generic DPI substitution. Some patients have doubts about their ability to successfully navigate differences in generic device design, and most expressed the desire to participate in discussions and decision-making with their HCP about generic DPI sameness and substitution.

31 October 2019 in Journal of Health Communication
Verified
Journal Article
Open access
JPJon A. Poehlman
Jon A. Poehlman
TSTurquoise Sidibe
Turquoise Sidibe
KJKarla V. Jimenez-Magdaleno
Karla V. Jimenez-Magdaleno
NVNatasha Vazquez
Natasha Vazquez
SRSarah E. Ray
Sarah E. Ray
LSLinda Braffird Squiers
Linda Braffird Squiers
Responding to an emerging health threat often requires rapid deployment of behavior change communication. Health communication best practices include developing and testing draft messages and materials to ensure that they resonate with and inspire priority groups to act. However, when faced with an emergency health threat, the timeline for these activities can be compressed from months to weeks. This article discusses the rapid development and implementation of a Zika virus prevention campaign for pregnant women in Puerto Rico. The goal of the campaign was to increase knowledge among and motivate pregnant women, their partners and family members, and the community to follow Zika virus prevention recommendations. The steps in campaign development include environmental scanning, concept development and testing, and message testing to ensure development of campaign materials that resonated with and were well-received by key audience groups. The materials adhere to principles of behavior change communication, and offer our insights for development of future campaigns when under time constraints.

25 September 2022 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
SRSarah E Ray
Sarah E Ray
VBVanessa Boudewyns
Vanessa Boudewyns
CDChristine Davis
Christine Davis
JTJanice P Tzeng
Janice P Tzeng
ISIla Srivastava
Ila Srivastava
KFKaren B Feibus
Karen B Feibus
Corrigendum for the article Patient Perceptions of Switching to a Generic Dry Powder Inhaler – Increased Understanding Through Journey Mapping